CT-526

N/A

Report date: 2023/01/07 16:59:35
NME

Base Information

Drug NameCT-526
Drug Alias NameCT-526
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 5 activators
TargetsCyclin-dependent kinase 5
Therapy Area/IndicationsFrontotemporal Dementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCogentis Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCogentis Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsFrontotemporal Dementia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A